Find clinical trials for Triple Negative Breast Cancer in St Louis, MO
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near St Louis, MO, USA:
This study will look to establish the recommended biologic dose of AE37 in combination with pembrolizumab that will enhance the tumor-specif-...
Phase 2
Swansea, Illinois, United States and 5 other locations
of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...
Phase 1, Phase 2
St Louis, Missouri, United States and 31 other locations
and nivolumab with neoadjuvant chemotherapy will decrease tumor associated macrophages (TAMs) and increase tumor infiltrating lymph-...
Phase 1, Phase 2
Saint Louis, Missouri, United States
(SG) given at an alternative dose and schedule, in participants with triple-negative breast cancer (TNBC).The pri...
Phase 1, Phase 2
St Louis, Missouri, United States and 14 other locations
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Swansea, Illinois, United States and 216 other locations
and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen rec...
Phase 2, Phase 3
O'Fallon, Illinois, United States and 283 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
St Louis, Missouri, United States and 283 other locations
(ABBV-181) and/or chemotherapy in participants with selected solid tumors. This study consists of 2 main parts, a dose-escalation phase and ...
Phase 1
Saint Louis, Missouri, United States and 26 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
St Louis, Missouri, United States and 275 other locations
This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors....
Phase 1, Phase 2
St Louis, Missouri, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal